Protein Structure Prediction Platforms Market Report 2026

Protein Structure Prediction Platforms Market Overview

• Protein Structure Prediction Platforms market size has reached to $1.75 billion in 2025 • Expected to grow to $3.62 billion in 2030 at a compound annual growth rate (CAGR) of 15.7% • Growth Driver: Rising Demand For Personalized Medicine Driving The Market Growth Due To Advances In Genomic Technologies And Increasing Approval Of Targeted Therapies • Market Trend: Advancements In AI-Driven Structure-Based Computational Biology For Enhanced Drug Discovery • Asia-Pacific was the largest region and fastest growing region.

What Is Covered Under Protein Structure Prediction Platforms Market?

Protein structure prediction platforms refer to computational systems that use advanced algorithms, machine learning, and bioinformatics tools to predict the three-dimensional (3D) structure of proteins from their amino acid sequences. These platforms help researchers accelerate drug discovery, understand protein function, and reduce reliance on time-consuming experimental methods such as X-ray crystallography and NMR spectroscopy. The main components of protein structure prediction platforms include software and services. Software refers to platforms that leverage computational methods to predict three-dimensional protein structures, aiding in research and drug discovery. These solutions utilize technologies such as artificial intelligence-based methods, homology modeling, ab initio approaches, threading, and hybrid methods and are deployed through cloud-based and on-premises models. They are applied in drug discovery, disease research, academic research, biotechnology, and other applications, and are utilized by end users, including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and other end users.

What Is The Protein Structure Prediction Platforms Market Growth Forecast?

The protein structure prediction platforms market size is expected to see rapid growth in the next few years. It will grow to $3.62 billion in 2030 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to adoption of advanced ai and ml algorithms, expansion of cloud-based platforms, integration with biopharmaceutical pipelines, rising investment in computational biology, demand for high-throughput protein modeling. Major trends in the forecast period include ai-driven protein structure prediction, cloud-based computational platforms, integration with drug discovery pipelines, real-time molecular modeling, predictive disease research analytics.

Global Protein Structure Prediction Platforms Market Segmentation

1) By Component: Software, Services 2) By Technology: Artificial Intelligence-based, Homology Modeling, Ab Initio, Threading, Hybrid Methods 3) By Deployment Mode: Cloud-Based, On-Premises 4) By Application: Drug Discovery, Disease Research, Academic Research, Biotechnology, Other Applications 5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End Users Subsegments: 1) By Software: Structure Prediction Software, Molecular Modeling Software, Visualization And Analysis Software, Database Management Software, Workflow Automation And Simulation Software 2) By Services: Consulting And Implementation Services, Integration And Customization Services, Training And Technical Support Services, Maintenance And Upgrade Services, Data Analysis And Computational Services

What Is The Driver Of The Protein Structure Prediction Platforms Market?

The growing demand for personalized medicine is expected to propel the growth of the protein structure prediction platforms market going forward. Personalized medicine is an approach that customizes healthcare and therapies based on a patient’s unique biological and personal characteristics. The use of personalized medicine is increasing due to advances in genomic technologies, which allow healthcare providers to analyze a patient’s genetic information quickly and accurately, enabling more targeted and effective treatments. In research and drug development, protein structure prediction platforms support personalized medicine by allowing scientists to model patient-specific protein variants, understand mutation-driven structural changes, and design targeted therapies for genetically defined patient subgroups. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the protein structure prediction platforms industry.

Key Players In The Global Protein Structure Prediction Platforms Market

Major companies operating in the protein structure prediction platforms market are IBM Corporation, Thermo Fisher Scientific Inc., Dassault Systèmes SE, Charles River Laboratories International Inc., Bruker Corporation, Revvity Inc., DeepMind Technologies Limited, Schrödinger Inc., BenevolentAI Limited, Nimbus Therapeutics Inc., Arzeda Corporation, Relay Therapeutics Inc., LabVantage Solutions Inc., Genesis Therapeutics Inc., Bioinformatics Solutions Inc., Chemical Computing Group ULC, Insilico Medicine Inc., Cloud Pharmaceuticals Inc., Peptone Ltd., Molecular Forecaster Inc., Acellera Ltd., CD BioSciences, and ProteinLab.ai Inc.

Global Protein Structure Prediction Platforms Market Trends and Insights

Major companies operating in the protein structure prediction platforms market are focusing on developing innovative solutions such as, structure-based computational biology technologies to accelerate drug discovery, enable accurate protein modeling, and enhance target identification through advanced molecular simulations and AI-driven structural analysis. These systems leverage three-dimensional protein structure data, molecular modeling, and simulation algorithms to analyze biomolecular interactions and support rational drug design. For instance, in March 2024, Basecamp Research, a UK-based AI-driven biotechnology company, launched BaseFold, a deep learning model designed to improve 3D protein structure prediction for large and complex proteins. By augmenting AlphaFold2 with its proprietary BaseGraph dataset derived from global biodiversity sources, BaseFold demonstrated up to six-fold improvements in predictive accuracy and three-fold enhancements in small-molecule docking performance in internal benchmarks. Such advances underpin next-generation protein structure prediction platforms by improving the modeling of protein classes that have been underrepresented in public datasets, thereby supporting AI-driven drug discovery efforts.

What Are Latest Mergers And Acquisitions In The Protein Structure Prediction Platforms Market?

In October 2025, Eli Lilly and Company, a US-based pharmaceutical company, partnered with NVIDIA Corporation to develop an AI-powered supercomputing platform designed to advance protein structure prediction and structure-based drug discovery. The collaboration leverages NVIDIA’s accelerated computing and generative AI technologies to enable large-scale 3D protein modeling, molecular simulations, and protein–ligand interaction analysis. Through this partnership, the companies aim to improve target identification, optimize lead discovery, and accelerate the development of novel therapeutics by enhancing the accuracy and speed of AI-driven structural biology workflows. NVIDIA Corporation is a US-based technology company specializing in accelerated computing and artificial intelligence solutions.

Regional Insights

North America was the largest region in the protein structure prediction platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Protein Structure Prediction Platforms Market?

The protein structure prediction platforms market includes revenues earned by entities by providing services such as 3D protein structure modeling, homology modeling and template-based modeling, and protein–protein interaction analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data And Analysis Are Included In The Protein Structure Prediction Platforms Market Report 2026?

The protein structure prediction platforms market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the protein structure prediction platforms industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.